Full year 2025 revenue expected to be in the range of $3.30 billion to $3.45 billion and Adjusted EBITDA expected to be in the range of $555 million to $565 million/.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SGRY:
- Surgery Partners reports Q4 adjusted EPS 44c, consensus 38c
- SGRY Earnings Report this Week: Is It a Buy, Ahead of Earnings?
- BofA moves to No Rating on Surgery Partners after Bain offer
- Surgery Partners says committee to review $25.75 per share buyout proposal
- Surgery Partners confirms $25.75 per share buyout offer from Bain Capital
